Subsequently, E-cadherin expression decreases and correlates with progression to metastatic disease, in a manner similar to other carcinomas (Auersperg et al, 2002; Yuecheng et al, 2006) indicating ovarian cancer metastasis is likely promoted by the de-differentiation that accompanies E-cadherin downregulation. Here, CDH1 is linked to ovarian cancer.